Zacks Investment Research on MSN
This Top Finance Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
It doesn't matter if you're a growth, value, income, or momentum-focused investor -- building a successful investment portfolio takes skill, research, and a little bit of luck. But how do you find the ...
ARM's Q2 results are expected to show strong royalty and licensing gains, but after a 38% rally, investors may want to wait ...
Zacks Investment Research on MSNOpinion
The Best Top-Ranked Stocks to Buy Now in November
The stock market is trading just below all-time highs in the early days of November as Wall Street celebrates strong earnings ...
Zacks.com on MSN
HBAN vs. CBSH: Which Stock Is the Better Value Option?
We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank is a proven ...
Investors looking to add a couple of high-flying tech names to their portfolio should take a closer look at these two companies before they likely surge higher.
Zacks.com on MSN
Amarin's Q3 Earnings Lag Estimates, Revenues Beat, Stock Down
Detailed price information for Beam Therapeutics Inc (BEAM-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results